Fox Chase Cancer Center News

PHILADELPHIA (December 13, 2021)—Billy Truong, a doctoral candidate at Fox Chase Cancer Center, was awarded the American Society of Hematology (ASH) Abstract Achievement Award for a poster that he presented at the 63rd ASH Annual Meeting and Exposition.

PHILADELPHIA (December 2, 2021) – As new and pressing lung health challenges emerge due to factors such as the COVID-19 pandemic, climate change, and youth e-cigarette use, researchers continue to be at the forefront of scientific breakthroughs. In Philadelphia, two distinguished scientists from Fox Chase Cancer Center are being awarded research grants to help study how lung cancer impacts people’s lives.

PHILADELPHIA (December 2, 2021)—Fox Chase Cancer Center has opened an investigator-initiated, phase 1 clinical trial to evaluate the safety and efficacy of gamitrinib in patients with advanced cancer. Gamitrinib is a first-in-class, mitochondrial-targeted inhibitor of the molecular chaperone heat shock protein-90 (HSP90) that works by inhibiting tumor cell metabolism and survival.

PHILADELPHIA (December 1, 2021)—Cihangir Duy, PhD, MS, an assistant professor in the Cancer Signaling and Epigenetics Program at Fox Chase Cancer Center, has been awarded a two-year V Scholar Award of $200,000. This grant will fund research into how certain acute myeloid leukemia (AML) cells can reinitiate leukemia after chemotherapy.

PHILADELPHIA (November 30, 2021)—Suzanne M. Miller, PhD, a professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, has spearheaded a recent special edition of Translational Behavioral Medicine published today that summarizes several major lines of cancer prevention and control research and outlines future directions.

PHILADELPHIA (November 24, 2021)—Fox Chase Cancer Center is pleased to announce the hiring of Pamela Handelsman, PsyD, as an assistant professor in the Section of Psychiatry, where she will help patients cope with cancer across the entire care continuum, from initial diagnosis to end of life or survivorship.

PHILADELPHIA (November 22, 2021)—Jaye Gardiner, PhD, a postdoctoral researcher at Fox Chase Cancer Center, has received an inaugural Black in Cancer postdoctoral fellowship, which is funded by Emerald Foundation Inc. Gardiner will receive $75,000 annually for three years, money that will fund her research into pancreatic ductal adenocarcinoma (PDAC).  

PHILADELPHIA (November 22, 2021)—Fox Chase Cancer Center has begun using a new artificial intelligence-powered system called AlphaFold, which allows researchers to develop accurate predictions of how proteins fold into their final structures, making it a tool that could enhance the development of new drugs.